Patents by Inventor Jean-Christophe Califano

Jean-Christophe Califano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9802903
    Abstract: This invention is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: October 31, 2017
    Assignee: AbbVie Inc.
    Inventors: Jean-Christophe Califano, James J. Napier, Calvin L. Becker, Su Yu
  • Patent number: 9593078
    Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern as shown in one of FIGS. 1-10.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: March 14, 2017
    Assignee: AbbVie Inc.
    Inventors: Jean-Christophe Califano, Michael G. Fickes, Lars Fredrik Nordstroem
  • Publication number: 20160090373
    Abstract: Disclosed are crystalline forms of a compound of formula (I), methods of their preparation, and related pharmaceutical preparations thereof.
    Type: Application
    Filed: September 28, 2015
    Publication date: March 31, 2016
    Inventors: Jean-Christophe Califano, Michael G. Fickes, Lars F. Nordstroem
  • Publication number: 20160060228
    Abstract: This invention is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.
    Type: Application
    Filed: November 10, 2015
    Publication date: March 3, 2016
    Inventors: Jean-Christophe Califano, James J. Napier, Calvin L. Becker, Su Yu
  • Patent number: 9238652
    Abstract: Provided herein is a process for the preparation of an apoptosis-inducing agent, and chemical intermediates thereof. Also provided herein are novel chemical intermediates related to the process provided herein.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: January 19, 2016
    Assignee: AbbVie Inc.
    Inventors: Jufang Barkalow, Jean-Christophe Califano, Vincent S. Chan, Alan C. Christesen, Timothy A. Grieme, Yi-Yin Ku, Mathew M. Mulhern, Yu-Ming M. Pu
  • Patent number: 9216952
    Abstract: This invention is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: December 22, 2015
    Assignee: AbbVie Inc.
    Inventors: Jean-Christophe Califano, James J. Napier, Calvin L. Becker, Su Yu
  • Publication number: 20150322047
    Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern as shown in one of FIGS. 1-10.
    Type: Application
    Filed: May 8, 2015
    Publication date: November 12, 2015
    Applicant: AbbVie Inc.
    Inventors: Jean-Christophe Califano, Michael G. Fickes, Lars Fredrik Nordstroem
  • Publication number: 20150252042
    Abstract: Provided herein is a process for the preparation of an apoptosis-inducing agent, and chemical intermediates thereof. Also provided herein are novel chemical intermediates related to the process provided herein.
    Type: Application
    Filed: March 4, 2015
    Publication date: September 10, 2015
    Inventors: Jufang Barkalow, Jean-Christophe Califano, Vincent S. Chan, Alan C. Christesen, Timothy A. Grieme, Yi-Yin Ku, Mathew M. Mulhern, Yu-Ming M. Pu
  • Publication number: 20110237793
    Abstract: This invention is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.
    Type: Application
    Filed: March 23, 2011
    Publication date: September 29, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Jean-Christophe Califano, James J. Napier
  • Patent number: RE48923
    Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern as shown in one of FIGS. 1-10.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: February 8, 2022
    Assignee: AbbVie Inc.
    Inventors: Jean-Christophe Califano, Michael G. Fickes, Lars Fredrik Nordstroem